KRTAP5-10
gene geneOn this page
Also known as KRTAP5.10
Summary
KRTAP5-10 (keratin associated protein 5-10, HGNC:23605) is a protein-coding gene on chromosome 11q13.4, encoding Keratin-associated protein 5-10 (Q6L8G5). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….
Predicted to be located in cytosol.
Source: NCBI Gene 387273 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_001012710
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23605 |
| Approved symbol | KRTAP5-10 |
| Name | keratin associated protein 5-10 |
| Location | 11q13.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRTAP5.10 |
| Ensembl gene | ENSG00000204572 |
| Ensembl biotype | protein_coding |
| Entrez | 387273 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000398531
RefSeq mRNA: 1 — MANE Select: NM_001012710
NM_001012710
CCDS: CCDS41684
Canonical transcript exons
ENST00000398531 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001533489 | 71565563 | 71566735 |
Expression profiles
Bgee: expression breadth ubiquitous, 108 present calls, max score 85.02.
Top tissues by expression
126 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.02 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.38 | silver quality |
| right uterine tube | UBERON:0001302 | 56.02 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 53.18 | gold quality |
| putamen | UBERON:0001874 | 51.50 | gold quality |
| mucosa of stomach | UBERON:0001199 | 50.22 | gold quality |
| tibial nerve | UBERON:0001323 | 49.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 49.57 | gold quality |
| nucleus accumbens | UBERON:0001882 | 49.39 | gold quality |
| skin of leg | UBERON:0001511 | 49.32 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 49.15 | gold quality |
| caudate nucleus | UBERON:0001873 | 49.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 48.85 | gold quality |
| zone of skin | UBERON:0000014 | 48.73 | gold quality |
| skin of abdomen | UBERON:0001416 | 48.57 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 48.14 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.04 | silver quality |
| cortex of kidney | UBERON:0001225 | 47.61 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 46.59 | gold quality |
| prostate gland | UBERON:0002367 | 46.49 | gold quality |
| fallopian tube | UBERON:0003889 | 46.42 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 46.22 | gold quality |
| tibial artery | UBERON:0007610 | 45.99 | gold quality |
| popliteal artery | UBERON:0002250 | 45.95 | gold quality |
| adenohypophysis | UBERON:0002196 | 45.69 | gold quality |
| urinary bladder | UBERON:0001255 | 45.39 | gold quality |
| cerebellum | UBERON:0002037 | 45.33 | silver quality |
| gastrocnemius | UBERON:0001388 | 45.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 45.25 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 45.11 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting KRTAP5-10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-3160-3P | 99.07 | 64.78 | 955 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-6830-5P | 99.01 | 68.73 | 1884 |
| HSA-MIR-6760-5P | 98.87 | 66.73 | 1515 |
| HSA-MIR-6894-5P | 98.70 | 63.78 | 809 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-5187-5P | 98.54 | 67.94 | 952 |
| HSA-MIR-1199-5P | 98.44 | 66.51 | 829 |
| HSA-MIR-6751-3P | 98.44 | 66.35 | 835 |
| HSA-MIR-211-3P | 98.14 | 66.77 | 1052 |
| HSA-MIR-493-3P | 97.50 | 66.44 | 731 |
| HSA-MIR-558 | 97.50 | 67.16 | 977 |
| HSA-MIR-125A-3P | 97.04 | 66.92 | 902 |
| HSA-MIR-552-3P | 96.68 | 64.12 | 1026 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-4264 | 96.35 | 64.76 | 1480 |
| HSA-MIR-1245A | 96.33 | 66.25 | 498 |
| HSA-MIR-8079 | 96.33 | 66.11 | 484 |
| HSA-MIR-6853-5P | 93.94 | 61.88 | 114 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 5-10 — Q6L8G5 (reviewed: Q6L8G5)
Alternative names: Keratin-associated protein 5.10, Ultrahigh sulfur keratin-associated protein 5.10
All UniProt accessions (1): Q6L8G5
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Expressed in hair root but not in skin. Expressed also in brain and skeletal muscle.
Similarity. Belongs to the KRTAP type 5 family.
RefSeq proteins (1): NP_001012728* (*=MANE)
Domains & families (InterPro)
UniProt features (9 total): repeat 7, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6L8G5-F1 | 45.90 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 18 (showing top):
chr11q13, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, MARTENS_TRETINOIN_RESPONSE_UP, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_EGF_INTERVAL_UP, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR4441, MIR3185, MIR4270, MIR12128, MIR6754_5P, MIR5187_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
208 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP5-10 | OR2G3 | Q8NGZ4 | 631 |
| KRTAP5-10 | OR2G2 | Q8NGZ5 | 585 |
| KRTAP5-10 | KRTAP5-7 | Q6L8G8 | 582 |
| KRTAP5-10 | OR13G1 | Q8NGZ3 | 537 |
| KRTAP5-10 | OR6F1 | Q8NGZ6 | 518 |
| KRTAP5-10 | AQP12B | A6NM10 | 512 |
| KRTAP5-10 | OR14A16 | Q8NHC5 | 509 |
| KRTAP5-10 | OR1C1 | Q15619 | 496 |
| KRTAP5-10 | OR11L1 | Q8NGX0 | 475 |
| KRTAP5-10 | OR4M2 | Q8NGB6 | 447 |
| KRTAP5-10 | OR4N4 | Q8N0Y3 | 446 |
| KRTAP5-10 | FAM86C1P | Q9NVL1 | 435 |
| KRTAP5-10 | AQP12A | Q8IXF9 | 393 |
| KRTAP5-10 | ZNF480 | Q8WV37 | 380 |
| KRTAP5-10 | ANKRD13D | Q6ZTN6 | 379 |
IntAct
0 interactions, top by confidence:
BioGRID (1): KRTAP5-10 (Negative Genetic)
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YF01, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, C0J7L8, O08884, P04459, P18165, P26371, P26372, Q01644, Q02957, Q02958, Q3LI54, Q3LI58, Q3LI59, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI70, Q3LI72, Q3SYF9, Q62220, Q64507, Q6L8G5, Q6L8H1, Q6L8H2, Q6L8H4, Q701N2, Q701N4, Q7Z4W3, Q8C1I6, Q8IUB9, Q925H2, Q925H3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
320 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:71565776:C:G | donor_gain | 0.9700 |
| 11:71565801:G:GT | donor_gain | 0.9500 |
| 11:71565635:T:TA | donor_gain | 0.9000 |
| 11:71565775:GCT:G | donor_gain | 0.8800 |
| 11:71566405:A:AG | acceptor_gain | 0.8800 |
| 11:71566406:G:GG | acceptor_gain | 0.8800 |
| 11:71565832:G:GT | donor_gain | 0.8700 |
| 11:71565610:G:GT | donor_gain | 0.8600 |
| 11:71566184:GT:G | donor_gain | 0.8600 |
| 11:71566404:CAGGA:C | acceptor_loss | 0.8600 |
| 11:71566405:A:T | acceptor_loss | 0.8600 |
| 11:71566406:G:GT | acceptor_loss | 0.8600 |
| 11:71566404:CAGG:C | acceptor_gain | 0.8500 |
| 11:71566405:AGGA:A | acceptor_gain | 0.8500 |
| 11:71566406:GGA:G | acceptor_gain | 0.8500 |
| 11:71566406:GGAG:G | acceptor_gain | 0.8500 |
| 11:71565613:G:GT | donor_gain | 0.8400 |
| 11:71565636:T:TA | donor_gain | 0.8300 |
| 11:71565780:G:GA | donor_gain | 0.8100 |
| 11:71565804:G:T | donor_gain | 0.8100 |
| 11:71566405:AG:A | acceptor_gain | 0.8100 |
| 11:71566406:GG:G | acceptor_gain | 0.8100 |
| 11:71566493:C:A | acceptor_gain | 0.8100 |
| 11:71565737:GCCC:G | donor_gain | 0.8000 |
| 11:71565631:G:GT | donor_gain | 0.7800 |
| 11:71566399:T:TA | acceptor_gain | 0.7800 |
| 11:71565802:G:T | donor_gain | 0.7500 |
| 11:71566287:G:GC | acceptor_gain | 0.7400 |
| 11:71565804:G:GT | donor_gain | 0.7300 |
| 11:71566275:C:CA | acceptor_gain | 0.7300 |
AlphaMissense
1304 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:71566158:A:C | S191R | 0.668 |
| 11:71566160:C:A | S191R | 0.668 |
| 11:71566160:C:G | S191R | 0.668 |
| 11:71565890:G:C | K101N | 0.644 |
| 11:71565890:G:T | K101N | 0.644 |
| 11:71565737:G:C | K50N | 0.637 |
| 11:71565737:G:T | K50N | 0.637 |
| 11:71566098:A:C | S171R | 0.631 |
| 11:71566100:C:A | S171R | 0.631 |
| 11:71566100:C:G | S171R | 0.631 |
| 11:71565860:G:C | K91N | 0.626 |
| 11:71565860:G:T | K91N | 0.626 |
| 11:71565920:G:C | K111N | 0.626 |
| 11:71565920:G:T | K111N | 0.626 |
| 11:71565950:A:C | K121N | 0.626 |
| 11:71565950:A:T | K121N | 0.626 |
| 11:71566161:T:C | C192R | 0.612 |
| 11:71566128:A:C | S181R | 0.600 |
| 11:71566130:C:A | S181R | 0.600 |
| 11:71566130:C:G | S181R | 0.600 |
| 11:71566178:C:G | C197W | 0.599 |
| 11:71566118:C:G | C177W | 0.584 |
| 11:71566176:T:C | C197R | 0.582 |
| 11:71565949:A:T | K121I | 0.577 |
| 11:71566190:G:C | K201N | 0.572 |
| 11:71566190:G:T | K201N | 0.572 |
| 11:71566192:T:G | I202S | 0.569 |
| 11:71566166:T:G | C193W | 0.568 |
| 11:71566163:C:G | C192W | 0.566 |
dbSNP variants (sampled 300 via entrez): RS1002822159 (11:71566695 T>C), RS1006482098 (11:71563801 A>G), RS1006672005 (11:71566941 A>T), RS1006983508 (11:71566800 T>C), RS1010329335 (11:71564235 A>C), RS1011146946 (11:71567184 C>A), RS1011936039 (11:71563733 G>A,T), RS1012782319 (11:71566417 T>G), RS1013486164 (11:71563586 C>A,T), RS1013501919 (11:71563748 C>T), RS1014490754 (11:71564887 C>T), RS1017409008 (11:71565095 C>T), RS1019692584 (11:71566958 C>T), RS1020364065 (11:71564570 T>C), RS1020511789 (11:71564236 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| arsenic disulfide | increases methylation | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.